The IGF1/IGF1R system dysregulation is involved in the proliferation of numerous tumours [47] as well as the IGF1/IGF1R system inhibition by statins, which may be of preventive and/or therapeutic value in some tumours such as prostate [48]. This evidence concerns the gene IGF1R and neoplasm.